High Throughput Screening Market By Technology Type (Cell Based Assays, Ultra High Throughput Screening, Lab-on-a-Chip, Bioinformatics, Label Free Technology), By Application (Target Identification, Primary & Secondary Screening, Toxicology Assessment, Others), By End User (Biotechnology & Pharmaceutical Industries, Academic & Government Research Institutes, Contract Research Organizations, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026
"High throughput screening market to exhibit productive growth during the forecast period"
The global high throughput screening (HTS) market is growing effectively, valued at US$ 13.2 Bn in 2017 and estimated to reach US$ 24.4 Bn by 2026. Increasing need for drug discovery in pharmaceuticals & biotechnology will enhance the overall expansion of high throughput screening market globally. New technology assessment in the field of cell based assays is significant; the fluorometric imaging plate reader cell based assays will drive the market in developed nations. New automated platforms for ultra high throughput screening will gain traction globally. Additionally, adoption of advanced testing and detection platforms, utilization of 3D based cultures, and better funding from research organizations or public sources will further spur revenue growth during the forecast period.
Factors driving the HTS market growth in developed nations comprise easy affordability of novel automated platforms, increasing need for new therapies, and rapid new product launches. Nevertheless, high cost of automated systems, lack of infrastructure, and economic issues with complex HTS and R&D are few factors limiting the growth of high throughput screening market globally.
"Ultra high throughput screening (uHTS) in drug discovery expected to register higher growth by 2026"
High throughput screening technologies are categorized into cell based assays, ultra high throughput screening, lab-on-a-chip, bioinformatics and label free technology. Increasing number of drug targets for primary & secondary screening, research funding by government, private and research institutes are boosting the overall growth in developed nations.
Current trends show improvement in chemical libraries and advanced software along with automation techniques with high standards and enhanced outcomes via screening procedures. Increasing need for newer treatments for a number of disease conditions is supporting new technology assessment in high throughput screening. Currently, drug discovery platforms with ultra high throughput screening is well-defined by screening numbers. However, high cost and less efficiency of advanced software for liquid handling systems, plate reader detection and automated robotic arms has a negative impact on the market.
"Drug discovery platforms to witness a significant CAGR"
The high throughput screening techniques are utilized in various application areas such as target identification, primary & secondary screening, toxicology assessment, and others. Pharmaceutical & biotech companies have funded for a wide scale of automated systems to upsurge the adoption of throughput screening across the early stages for drug discovery processes.
The rise in usage of ultra high-throughput screening and advanced robotic platforms is generating maximum revenue share. Additionally, noteworthy development in the specialized instrumentation, such as multi-mode microplate readers will gain traction globally. HTS process are evolved in carrying out various procedures in an automated environment using a custom-engineered 3D imaging system. For instance, in November 2018, NTRC (Netherlands Translational Research Center) launched the first high-throughput screening assay for arginase-1 inhibitors at ENA2018. Other applications such as automating target-based and complex phenotypic drug discovery, cytotoxicity detection and advanced primary screening in cell based assays show promising opportunity during the forecast period.
"Increasing applications in biotechnology and pharmaceutical industry witness a significant CAGR"
High throughput screening processes are utilized in various areas, having prime occupation in pharmaceutical and biotechnology. Due to numerous technology assessments taking place on drug discovery platforms, various small and medium size pharmaceutical and biotech companies are intensively focused on development of novel molecules for numerous life threatening disorders.
Moreover, huge investments in the biotech & pharmaceutical industry, for high throughput screening technology in terms of miniaturization, automation, and assay methodology, have helped in market growth globally. Additionally, the end-users of HTS market have perceived growing number of clinical candidates, and marketed drugs, arising from the advance techniques utilized.
"High demand, new product launches and the presence of top players holds North America in dominant position"
At present, North America (dominantly, the U.S.) generated maximum market share in the global market accredited to new product launches along with advanced automation techniques. Convenient access to HTS laboratories facilitating advanced assay technologies for performing primary and secondary screening campaigns is on a rise in the U.S.
Other prominent factors leading the market growth include the demand for extensive automation techniques in HTS, increased research and development activities on toxicology and stem cells, integration of advanced data management & information systems. However, high cost, limited availability of automated systems, lack of trained staff, and complexity in assay development and techniques are limiting the growth of HTS market.
"Dominance of multinational manufacturers with strong product portfolio in the developed regions"
Major players in the high throughput screening market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Tecan Group Ltd., Aurora Biomed, Perkinelmer, Inc., Sigma Aldrich Corporation, Axxam Spa, Hamilton Company, Aurora Biomed, Inc., Danaher Corporation, Beckman Coulter Inc., GE Healthcare and others. Topmost corporations are manufacturing high throughput screening in an advanced automated environment. Additionally, partnerships with other companies, research organizations and academic institutes will further drive the market growth. For instance, in February 2018, Charles River Laboratories declared a new agreement which grants the commercial access to AstraZeneca’s high-throughput screening systems and compound management infrastructure. The company will perform high-throughput screening programs by utilizing AstraZeneca’s hi-tech HTS facility.
Historical & Forecast Period
This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.
This report also comprehends qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall high throughput screening market. Additionally, the report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current and future trends in high throughput screening?
- What are the current dynamics in the automated systems and valuable opportunities for emerging players?
- Which application segment accounts for the fastest CAGR during the forecast period?
- Which end user type holds a larger market share and why?
- What is the impact of high cost of automated systems in the high throughput screening market?
- What are the products and brands in the HTS industry that are growing more significantly and why?
- What is the impact of information data systems in the global market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global HTS Market Portraiture
2.2. Global HTS Market, by Technology Type, 2017 (US$ Bn)
2.3. Global HTS Market, by Application, 2017 (US$ Bn)
2.4. Global HTS Market, by End User, 2017 (US$ Bn)
2.5. Global HTS Market, by Geography, 2017US$ Bn)
Chapter 3. Global High Throughput Screening (HTS) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. HTS Market Technologies: Future Trends
3.3. Drivers
3.3.1. Driver 1
3.3.2. Driver 2
3.4. Challenges
3.4.1. Challenge 1
3.4.2. Challenge 2
3.5. Opportunities
3.5.1. Opportunity 1
3.5.2. Opportunity 2
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global High Throughput Screening (HTS) Market, by Technology Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.2. Cell Based Assays
4.3. Ultra High Throughput Screening
4.4. Lab-on-a-Chip
4.5. Bioinformatics
4.6. Label Free Technology
Chapter 5. Global High Throughput Screening (HTS) Market, by Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Target Identification
5.3. Primary & Secondary Screening
5.4. Toxicology Assessment
5.5. Others
Chapter 6. Global High Throughput Screening (HTS) Market, by End User, 2016 – 2026 (US$)
6.1. Overview
6.2. Biotechnology & Pharmaceutical Industries
6.3. Academic & Government Research Institutes
6.4. Contract Research Organizations
6.5. Others
Chapter 7. Global High Throughput Screening (HTS) Market, by Geography, 2016 – 2026 (US$ Bn)
7.1. Overview
7.2. North America HTS Market Analysis, 2016 – 2026
7.2.1. North America HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.2.2. North America HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.2.3. North America HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.2.4. North America HTS Market, by Country, 2016 – 2026 (US$ Bn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe HTS Market Analysis, 2016 – 2026
7.3.1. Europe HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.3.2. Europe HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.3.3. Europe HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.3.4. Europe HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific HTS Market Analysis, 2016 – 2026
7.4.1. Asia Pacific HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.4.2. Asia Pacific HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.4.3. Asia Pacific HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.4.4. Asia Pacific HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America HTS Market Analysis, 2016 – 2026
7.5.1. Latin America HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.5.2. Latin America HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.5.3. Latin America HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.5.4. Latin America HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) HTS Market Analysis, 2016 – 2026
7.6.1. MEA HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.6.2. MEA HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.6.3. MEA HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.6.4. MEA HTS Market, by Region, 2016 – 2026 (US$ Bn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Bio-Rad Laboratories
8.3. Agilent Technologies, Inc.
8.4. Tecan Group Ltd.
8.5. Aurora Biomed
8.6. Perkinelmer, Inc.
8.7. Sigma Aldrich Corporation
8.8. Axxam Spa
8.9. Hamilton Company
8.10. Aurora Biomed, Inc.
8.11. Danaher Corporation
8.12. GE Healthcare
* HTS - High Throughput Screening
TABLE 1 Market Snapshot: Global High Throughput Screening (HTS) Market
TABLE 2 Global HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 3 Global HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 4 Global HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 5 Global HTS Market, by Geography, 2016–2026 (US$ Bn)
TABLE 6 North America HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 7 North America HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 8 North America HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 9 North America HTS Market, by Country, 2016–2026 (US$ Bn)
TABLE 10 Europe HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 11 Europe HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 12 Europe HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 13 Europe HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 14 Latin America HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 15 Latin America HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 16 Latin America HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 17 Latin America HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 18 Asia Pacific HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 19 Asia Pacific HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 20 Asia Pacific HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 21 Asia Pacific HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 22 Middle East & Africa HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 23 Middle East & Africa HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 24 Middle East & Africa HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 25 Middle East & Africa HTS Market, by Region, 2016–2026 (US$ Bn)
TABLE 26 Thermo Fisher Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Bio-Rad Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Agilent Technologies, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Tecan Group Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Aurora Biomed: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 PerkinElmer, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 GE Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Sigma Aldrich Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Axxam Spa: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 35 Hamilton Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 36 Aurora Biomed, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
FIG. 1 Global High Throughput Screening (HTS) Market Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global HTS Market Segmentation
FIG. 4 Global HTS Market, by Technology Type, 2017 (US$ Bn)
FIG. 5 Global HTS Market, by Application, 2017 (US$ Bn)
FIG. 6 Global HTS Market, by End User, 2017 (US$ Bn)
FIG. 7 Global HTS Market, by Geography, 2017 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key High Throughput Screening Solutions Manufacturers, 2017
FIG. 10 Global Cell Based Assays for HTS Market, 2016–2026 (US$ Bn)
FIG. 11 Global Ultra HTS Market, 2016–2026 (US$ Bn)
FIG. 12 Global Lab-on-a-Chip for HTS Market, 2016–2026 (US$ Bn)
FIG. 13 Global Bioinformatics for HTS Market, 2016–2026 (US$ Bn)
FIG. 14 Global Label Free Technology for HTS Market, 2016–2026 (US$ Bn)
FIG. 15 Global Drug Discovery Platforms Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 16 Global Primary & Secondary Screening Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 17 Global Toxicology Assessment Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 18 Global Other Applications for HTS Market, 2016–2026 (US$ Bn)
FIG. 19 Global HTS Market in Biotech & Pharma Industries, 2016–2026 (US$ Bn)
FIG. 20 Global HTS Market in Academic & Government Research Institutes, 2016–2026 (US$ Bn)
FIG. 21 Global HTS Market in Contract Research Organizations, 2016–2026 (US$ Bn)
FIG. 22 Global HTS Market in Other End-Users, 2016–2026 (US$ Bn)
FIG. 23 U.S. HTS Market, 2016–2026 (US$ Bn)
FIG. 24 Canada HTS Market, 2016–2026 (US$ Bn)
FIG. 25 U.K. HTS Market, 2016–2026 (US$ Bn)
FIG. 26 Germany HTS Market, 2016–2026 (US$ Bn)
FIG. 27 Rest of Europe HTS Market, 2016–2026 (US$ Bn)
FIG. 28 Japan HTS Market, 2016–2026 (US$ Bn)
FIG. 29 China HTS Market, 2016–2026 (US$ Bn)
FIG. 30 Rest of Asia Pacific HTS Market, 2016–2026 (US$ Bn)
FIG. 31 Brazil HTS Market, 2016–2026 (US$ Bn)
FIG. 32 Mexico HTS Market, 2016–2026 (US$ Bn)
FIG. 33 Rest of Latin America HTS Market, 2016–2026 (US$ Bn)
FIG. 34 GCC HTS Market, 2016–2026 (US$ Bn)
FIG. 35 Rest of Middle East & Africa HTS Market, 2016–2026 (US$ Bn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)